What I Do and Why: HBV Treatment Strategies for Diverse Patient Populations

Download All
Featuring interactive multimedia modules, downloadable slidesets, and expert-authored ClinicalThought commentaries from US and European faculty, this program explores in depth why leading experts make specific HBV management decisions in their own practices and equips learners with key strategies for treating a diverse array of patients.
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Program Director
Maria Buti, MD
person default
Pietro Lampertico, MD, PhD

HBV Management in Europe

In this interactive virtual module, expert faculty discuss how they would manage complex patients with HBV infection, emphasizing European guidelines and perspectives.

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Program Director Maria Buti, MD person default Pietro Lampertico, MD, PhD Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Released: June 1, 2020 Expired: May 31, 2021
Module Overview (2 minutes)
Introduction to HBV Treatment Candidacy and Treatment Options (16 minutes)
Case 1: Pregnant Woman With Immune-Tolerant Chronic HBV Infection (14 minutes)
Case 2: HBeAg-Negative Patient With Slightly Elevated ALT (17 minutes)
Case 3: HBeAg-Negative Patient Wishing to Stop NA Therapy (24 minutes)

Review European guideline recommendations informing HBV management strategies for complex cases and learn how expert faculty would approach each case

Maria Buti, MD person default Pietro Lampertico, MD, PhD Released: June 1, 2020
Provided by Clinical Care Options, LLC
Contact Info

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Gilead Sciences

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue